Bio-Rad Reports Third-Quarter 2020 Financial Results.

Q3 NON-GAAP EARNINGS PER SHARE $3.00.
Q3 EARNINGS PER SHARE $43.64.
Q3 SALES $647.3 MILLION VERSUS REFINITIV IBES ESTIMATE OF $570.6 MILLION.
Q3 EARNINGS PER SHARE ESTIMATE $1.80 -- REFINITIV IBES DATA.
BIO RAD LABORATORIES - CURRENTLY BELIEVES FULL-YEAR 2020 YOY CURRENCY-NEUTRAL SALES MAY BE UP 5.9 TO 6.3 PERCENT.